ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

I-Pharm Consulting Group Limited

I-Pharm Consulting Group Limited is an active company incorporated on 29 September 2017 with the registered office located in London, City of London. I-Pharm Consulting Group Limited was registered 8 years ago.
Status
Active
Active since 6 years ago
Company No
10988701
Private limited company
Age
8 years
Incorporated 29 September 2017
Size
Medium
Turnover is under £54M
Under 250 employees
Confirmation
Submitted
Dated 18 February 2025 (8 months ago)
Next confirmation dated 18 February 2026
Due by 4 March 2026 (4 months remaining)
Last change occurred 8 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Group
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
Moor Place, 1 Fore Street Avenue
Fore Street Avenue
London
EC2Y 9DT
England
Address changed on 13 Jan 2025 (9 months ago)
Previous address was Level 7 8 Devonshire Square London EC2M 4YJ England
Telephone
020 31892299
Email
Unreported
People
Officers
6
Shareholders
5
Controllers (PSC)
1
Director • Secretary • British
Director • Director • Irish • Lives in Northern Ireland • Born in Dec 1982
Director • British • Lives in UK • Born in May 1975
Director • British,irish • Lives in England • Born in Jun 1979
Mr Stephen Peter McAnaney
PSC • British • Lives in England • Born in Jun 1979
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
I-Pharm Consulting Limited
Steven James Lamport-Went, , and 2 more are mutual people.
Active
I-Pharm Consulting International Limited
Steven James Lamport-Went, Issam Adil Al-Tarafi, and 2 more are mutual people.
Active
Parallel Consulting Limited
Steven James Lamport-Went and are mutual people.
Active
Apollo Solutions Limited
Steven James Lamport-Went and are mutual people.
Active
White Knight Ventures Limited
Steven James Lamport-Went is a mutual person.
Active
Parallel Group Limited
Steven James Lamport-Went and Issam Adil Al-Tarafi are mutual people.
Active
Apollo Solutions Group Limited
Steven James Lamport-Went and Issam Adil Al-Tarafi are mutual people.
Active
Lex Exec Limited
Colin John Lynam is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2017–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£1.82M
Increased by £708K (+64%)
Turnover
£18.12M
Decreased by £10.19M (-36%)
Employees
66
Decreased by 47 (-42%)
Total Assets
£5.44M
Decreased by £3.38M (-38%)
Total Liabilities
-£1.19M
Decreased by £1.82M (-60%)
Net Assets
£4.25M
Decreased by £1.56M (-27%)
Debt Ratio (%)
22%
Decreased by 12.24% (-36%)
Latest Activity
Group Accounts Submitted
1 Month Ago on 30 Sep 2025
Own Shares Purchased
8 Months Ago on 3 Mar 2025
Confirmation Submitted
8 Months Ago on 19 Feb 2025
Colin John Lynam Resigned
9 Months Ago on 31 Jan 2025
Shares Cancelled
9 Months Ago on 31 Jan 2025
Mr Issam Adil Al-Tarafi Details Changed
9 Months Ago on 13 Jan 2025
Mr Steven James Lamport-Went Details Changed
9 Months Ago on 13 Jan 2025
Mr Steven James Lamport-Went Details Changed
9 Months Ago on 13 Jan 2025
Registered Address Changed
9 Months Ago on 13 Jan 2025
Own Shares Purchased
10 Months Ago on 9 Dec 2024
Get Credit Report
Discover I-Pharm Consulting Group Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Group of companies' accounts made up to 31 December 2024
Submitted on 30 Sep 2025
Director's details changed for Mr Steven James Lamport-Went on 13 January 2025
Submitted on 16 Sep 2025
Director's details changed for Mr Issam Adil Al-Tarafi on 13 January 2025
Submitted on 16 Sep 2025
Secretary's details changed for Mr Steven James Lamport-Went on 13 January 2025
Submitted on 16 Sep 2025
Purchase of own shares.
Submitted on 3 Mar 2025
Confirmation statement made on 18 February 2025 with updates
Submitted on 19 Feb 2025
Termination of appointment of Colin John Lynam as a director on 31 January 2025
Submitted on 11 Feb 2025
Cancellation of shares. Statement of capital on 29 January 2025
Submitted on 31 Jan 2025
Registered office address changed from Level 7 8 Devonshire Square London EC2M 4YJ England to Moor Place, 1 Fore Street Avenue Fore Street Avenue London EC2Y 9DT on 13 January 2025
Submitted on 13 Jan 2025
Purchase of own shares.
Submitted on 9 Dec 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year